If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.
https://www.aptamergroup.co.uk/find-out-more/partnerships :
[Aptamer Group partner] Paraytec
Competition Title: Technology Strategy Board CR&D Competition
Project Title: Novel Use of Aptamers and UV Area Imaging for Disease Detection
Lead Organisation: Paraytec
Total Grant Awarded: £149,632
This project brings together the innovative detection technology of Paraytec Ltd with the target recognition technology provided by Aptamer Diagnostic Ltd to create the next generation of detection instruments. These novel platforms will allow rapid field and point-of-care diagnosis based on multiplex detection of markers of disease or contamination. Simultaneous detection of multiple markers will reduce the ambiguity associated with diagnostic systems which look for single markers. It will also save both time and expense associated with routine laboratory based sample screening, allowing them to focus on samples where more detailed analysis is required.
Pokerchips has 'done the maths' and I agree with him. Still won't be buying any.
Yeah! Let's all buy a money leaking African airline during a global pandemic. Sounds like a recipe for success!
Well if you reckon it's going to 18p then why not just sell up and buy back in at that price yourself. Or better yet, find a share with better prospects and buy that. Either way it'll save us the earache.
End of the day it's an illiquid stock with a tiny free float so it doesn't take much buying pressure for it to move north. The inverse of that of course is that it moves south just as quickly.
In retrospect it was just a pump and dump and I should of sold on the spike and bought back in. But hey! Worst case scenario is that this'll be another TYM and get played by the pump crews until hopefully more substantial news regarding covid tests lands.
Traders selling on news I guess. Don't know why I bother TBH. The only time I make money on stocks is when I get in early on a really positive RNS and exit later that day or the following day.
OK it might be an illiquid stock in a severe market downturn, however it's NOT a 'jam tomorrow' affair. Their accounts showed a 100k loss before the pandemic began. All it will take is a few contract wins for this to re-rate massively IMHO. Their only problem is growth as the scope of the contracts they can undertake will be limited by their small size.
Don't get me wrong, I think that SYM is a promising company. However they will be publishing their accounts shortly (sometime in the next two weeks) and it won't make for pleasant reading as last year showed a 500k loss. I could be mistaken.. The accounts might not actually impact the share. After all this is the junior market where losses don't mean much compared to potential forward earnings. But I'm going to wait until they are published before I buy in again. Knowing my luck they would of rocketed on positive news way before then!
Not a deramp as such, just a heads up on what I perceive to be a potential (short term) road block.
It was mentioned briefly in their small cap section:
https://www.dailymail.co.uk/money/markets/article-8056587/SMALL-CAP-MOVERS-Novacyt-rare-riser-thanks-coronavirus-test.html
It might be a £500,000 loss for the whole year. So if revenues increase and they land some d2p contracts, then they might become profitable. Depends on how many contracts and how valuable those contracts are I guess.
It wouldn't be too surprising if they did place TBH. They might need a little bit more cash to fulfil their new d2p order book, but that's just a guess.